U.S. Electric Utilities Stock News

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...

If you are wondering whether Fiverr International's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are actually saying about value. The stock has seen sizeable declines recently, with a 7.7% fall over the last week, a 27.6% decline over the last month, a 46.8% drop year to date, and a 59.2% decline over the past year. This extends a 68.5% and 95.3% fall across the last 3 and 5 years respectively. Recent attention on Fiverr...

Capricor Therapeutics (CAPR) has just posted its FY 2025 first half results with total revenue of US$0 million and a basic EPS loss of US$1.10, while trailing twelve month revenue sits at US$13.39 million with a basic EPS loss of US$1.66. Over recent periods, the company has reported revenue of US$8.88 million and US$13.39 million across the two halves of FY 2024, alongside basic EPS losses of US$0.66 and US$0.51. This provides context for how current margins remain under pressure. With...

Orchestra BioMed Holdings (OBIO) just posted a sharp step up in activity for FY 2025, with fourth quarter revenue at US$30.9 million and basic EPS of US$0.10, compared with a full year where trailing twelve month revenue sat at US$33.5 million and EPS on that basis was a loss of US$1.11. The company has seen revenue move from quarterly levels below US$1 million through most of the year to the current US$30.9 million print, while quarterly basic EPS shifted from losses between US$0.49 and...

USA Compression Partners (NYSE:USAC) has agreed to acquire J-W Power, expanding its contract compression fleet and specialty manufacturing capabilities. The deal is positioned around asset repricing opportunities and deeper participation in compression equipment manufacturing. Management is framing the combination as a way to serve rising demand tied to LNG infrastructure and power needs from AI focused data centers. Industry capacity remains tight, with longer lead times for new compression...

Costco Wholesale (COST) has just turned in its Q2 2026 scorecard with revenue of US$69.6b and basic EPS of US$4.58, backed by net income of US$2.0b and 7% same store sales growth. The company has seen quarterly revenue move from US$63.2b in Q3 2025 to US$63.7b in Q2 2025 and then to US$69.6b in Q2 2026, while basic EPS has ranged from US$4.03 to US$5.88 over that stretch, setting the stage for investors to focus on how firmly margins are holding up behind the headline growth. See our full...

Burning Rock Biotech (NasdaqGM:BNR) has released its latest FY 2025 numbers with third quarter revenue of C¥131.6 million and a basic EPS loss of C¥1.56, alongside net income excluding extra items of a C¥16.8 million loss. The company has seen quarterly revenue range from C¥126.0 million to C¥148.6 million across the last six reported periods, while basic EPS moved between a loss of C¥0.90 and a much steeper loss of C¥10.53 over that time, which underscores the earnings pressure behind the...

Kyivstar Group (NasdaqGS:KYIV) has just posted its FY 2025 numbers with Q3 revenue at US$297 million and a net income loss of US$89 million, which translated into a basic EPS loss of US$0.41 for the quarter. The business has seen quarterly revenue move from US$248 million in Q3 2024 to US$297 million in Q3 2025. Over the same period, basic EPS shifted from US$0.40 in Q3 2024 to a loss of US$0.41 in Q3 2025, setting the scene for investors to weigh healthier top line figures against pressure...

Mid Penn Bancorp (MPB) closed out FY 2025 with fourth quarter total revenue of US$62.9 million and basic EPS of US$0.84, alongside net income of US$19.4 million. This capped a twelve month period where revenue reached US$224.6 million and EPS was US$2.59. Over the same trailing twelve month period, earnings grew at 10.3% per year over the past five years and are paired with analyst forecasts that indicate 28.22% annual earnings growth and 16.9% annual revenue growth. Investors can weigh these...

Open Lending (LPRO) has just wrapped up FY 2025 with Q4 revenue of US$19.3 million, basic EPS of US$0.01 and net income of US$1.7 million, giving investors a fresh read on how its lending enablement model is translating into the income statement. The company has seen quarterly revenue move from US$23.5 million in Q3 2024 to US$24.4 million in Q1 2025, US$25.3 million in Q2, US$24.2 million in Q3 and US$19.3 million in Q4, while basic EPS has swung between a loss of US$1.21 in Q4 2024 and...

Korro Bio (KRRO) has reported its FY 2025 numbers with Q4 revenue of US$1.3 million, a basic EPS loss of US$5.32 and a net income loss of US$50.0 million. Its trailing 12 month figures show revenue of US$6.4 million and a basic EPS loss of US$12.48 tied to a net loss of US$117.3 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q4 FY 2024 to between US$1.1 million and US$2.6 million across FY 2025. This has come alongside quarterly basic EPS losses ranging...

Academy Sports + Outdoors (NasdaqGS:ASO) is opening two new stores in North Canton, Ohio and Muskogee, Oklahoma. The company plans to open these locations as part of a broader rollout of 20 to 25 new stores in fiscal 2026. The new stores are expected to create about 120 local jobs and include charitable initiatives focused on local children. Academy Sports + Outdoors is a full line sporting goods and outdoor retailer. The new locations extend its reach into additional Midwest and South...

Artesian Resources (ARTNA) has wrapped up its latest quarter with Q3 FY 2025 revenue of US$30.5 million and basic EPS of US$0.68, alongside trailing 12 month revenue of US$111.8 million and EPS of US$2.19 that frame the broader earnings picture. Over recent quarters the company has seen revenue move from US$25.9 million and EPS of US$0.53 in Q1 FY 2025 to US$28.5 million and EPS of US$0.61 in Q2, before reaching the current Q3 levels. With trailing net profit margins at 20.2% and earnings up...

Nektar Therapeutics (NKTR) kicked off FY 2025 with a third quarter that paired modest revenue with deep losses, reporting Q3 revenue of US$11.8 million, basic EPS of a US$1.87 loss and a net income loss of US$35.5 million. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 and US$24.1 million in Q3 2024 to US$10.5 million, US$11.2 million and US$11.8 million over the first three quarters of 2025. Basic EPS shifted from a US$3.76 loss and US$2.66 loss in Q2 and Q3 2024...

Omega Flex (OFLX) just wrapped up FY 2025 with fourth quarter revenue of US$25.2 million and EPS of US$0.34, alongside trailing twelve month revenue of US$98.3 million and EPS of US$1.47 that sit below the prior year’s trailing figures of US$101.7 million and US$1.78 respectively. Over recent periods, quarterly revenue has moved in a tight band between US$23.3 million and US$26.0 million while quarterly EPS has ranged from US$0.35 to US$0.46. This puts the spotlight squarely on how...

GPGI (GPGI) has just posted its FY 2025 first half results, with revenue of US$59.8 million and a basic EPS loss of US$0.05, alongside trailing 12 month revenue of US$59.8 million and a net loss of US$136.0 million. Over the past three reported halves, revenue has moved from US$212.6 million in 1H 2024 to US$208.0 million in 2H 2024 and now US$59.8 million in 1H 2025. Basic EPS has shifted from a profit of US$1.11 in 1H 2024 to losses of US$1.22 in 2H 2024 and US$0.05 in the latest period,...

ProQR Therapeutics (NasdaqCM:PRQR) has wrapped up FY 2025 with fourth quarter revenue of €4.7 million and a basic EPS loss of €0.08, alongside a net income loss of €8.9 million. These figures put hard numbers around where the business stands today. Over recent periods the company has seen quarterly revenue range from €2.9 million to €4.7 million, while quarterly basic EPS has moved between a loss of €0.12 and a loss of €0.08. As a result, the story for investors remains centered on how...

Beauty Health (SKIN) closed FY 2025 with fourth quarter revenue of US$82.4 million and a basic EPS loss of US$0.06, alongside trailing twelve month revenue of US$300.8 million and a basic EPS loss of US$0.08. The company has seen quarterly revenue move between US$69.6 million and US$83.5 million over the recent periods. Basic EPS has ranged from a profit of US$0.16 per share in Q2 2025 to losses of around US$0.08 to US$0.15 per share in other quarters, setting up a mixed picture for margins...

Whitehawk Therapeutics (WHWK) has opened FY 2025 with first half revenue of US$7.1 million and Basic EPS of US$0.37, following a FY 2024 second half that saw revenue of US$14.5 million and a loss per share of US$1.14. Over the past year, the company has moved from Basic EPS of a US$2.36 loss on US$26.0 million of trailing twelve month revenue to a US$0.33 loss on US$7.1 million of trailing twelve month revenue, giving investors a clearer read on how its earnings profile and margins are...

AMREP (AXR) has released its Q3 2026 scorecard, with Q2 fiscal 2026 revenue of US$9.4 million and basic EPS of US$0.22, alongside trailing twelve month revenue of US$45.9 million and EPS of US$1.97 as investors weigh the latest move in margins. Over the past six reported quarters, the company has seen quarterly revenue range between US$7.5 million and US$19.1 million, while basic EPS has moved between US$0.13 and US$0.88. This provides a clear data trail on how the business has been...

Vaxart (VXRT) has reported another loss making quarter, with Q3 FY 2025 revenue of about US$72.4 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of roughly US$148.2 million and a basic EPS loss of US$0.22. Over recent periods, the company has seen quarterly revenue move from US$4.9 million in Q3 FY 2024 to US$15.2 million in Q4 FY 2024, then to US$20.9 million in Q1 FY 2025 and US$39.7 million in Q2 FY 2025. Basic EPS losses have ranged from US$0.09 in Q2 FY...

If you are wondering whether Payoneer Global's share price offers good value right now, you are not alone. This article focuses squarely on what the current market price might be implying. Payoneer Global's share price closed at US$4.43, with returns of an 8.7% decline over 7 days, a 26.2% decline over 30 days, an 18.6% decline year to date, a 37.6% decline over 1 year, a 27.7% decline over 3 years and a 60.2% decline over 5 years. Recent coverage around Payoneer Global has focused on its...